BioLargo Inc

General ticker "BLGO" information:

  • Sector: Materials
  • Industry: Chemicals
  • Capitalization: $56.8M

BioLargo Inc does not follow the US Stock Market performance with the rate: -15.3%.

Estimated limits based on current volatility of 5.4%: low 0.17$, high 0.19$

Factors to consider:

  • Earnings for 18 months up through Q2 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2022-12-31 to 2024-12-30

  • 2022-12-31 to 2023-12-31 estimated range: [0.11$, 0.27$]
  • 2023-12-31 to 2024-12-30 estimated range: [0.09$, 0.22$]

Financial Metrics affecting the BLGO estimates:

  • Negative: Non-GAAP EPS, $ of -0.02 <= 0.10
  • Negative: Operating profit margin, % of -47.54 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -4.98 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of 3.85 <= 3.85
  • Positive: 6.82 < Industry operating profit margin (median), % of 9.48

Similar symbols

Short-term BLGO quotes

Long-term BLGO plot with estimates

Financial data

YTD 2020-12-31 2021-12-31 2022-12-31
Operating Revenue $2.43MM $2.55MM $5.95MM
Operating Expenses $9.88MM $9.33MM $11.34MM
Operating Income $-7.45MM $-6.78MM $-5.39MM
Non-Operating Income $-2.25MM $-0.29MM $0.28MM
Interest Expense $1.92MM $0.23MM $0.05MM
R&D Expense $1.34MM $1.37MM $1.32MM
Income(Loss) $-9.70MM $-7.07MM $-5.11MM
Taxes $0.77MM $0.00MM $0.00MM
Profit(Loss) $-10.47MM $-7.07MM $-5.11MM
Stockholders Equity $3.86MM $4.65MM $4.88MM
Inventory $0.28MM $0.24MM $0.12MM
Assets $4.94MM $3.02MM $4.86MM
Operating Cash Flow $-4.15MM $-3.94MM $-2.76MM
Capital expenditure $0.02MM $0.03MM $0.27MM
Investing Cash Flow $-0.12MM $-0.03MM $-0.27MM
Financing Cash Flow $4.34MM $4.23MM $3.96MM
Earnings Per Share* $-0.05 $-0.03 $-0.02

* EPS are Split Adjusted, recent splits may be reflected with a delay.